BioSig Technologies Inc. | Small-cap | Healthcare
$11.55
10.95%
| BioSig Technologies Stock Comparison:
BioSig Technologies vs Abbott LaboratoriesBioSig Technologies vs Boston ScientificBioSig Technologies vs 908 DevicesBioSig Technologies vs MaxCyteBioSig Technologies vs Tactile SystemsBioSig Technologies vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 40.0K
Operating Income -12.6M -31,522.50%
Net Income -10.3M -25,847.50%

Balance Sheet Metrics

Total Assets 842.0K
Total Liabilities 2.3M
Shareholders Equity -1.4M

Cash Flow Metrics

Operating Cash Flow -3.2M
Free Cash Flow -4.8M

Revenue & Profitability Trend

BioSig Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue40.0K18.0K286.0K441.0K0
Cost of Goods Sold-057.0K199.0K0
Gross Profit-18.0K229.0K242.0K0
Operating Expenses12.5M28.2M27.2M33.5M59.1M
Operating Income-12.6M-28.5M-27.3M-33.4M-59.2M
Pre-tax Income-10.3M-28.7M-27.3M-32.9M-59.1M
Income Tax00000
Net Income-10.3M-28.7M-27.3M-32.9M-59.1M
EPS (Diluted)--$3.95-$6.33-$9.50-$18.70

Income Statement Trend

BioSig Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets344.0K528.0K1.1M13.9M29.3M
Non-Current Assets498.0K1.3M3.0M1.6M1.0M
Total Assets842.0K1.8M4.1M15.5M30.4M
Liabilities
Current Liabilities2.3M4.6M3.3M2.6M5.1M
Non-Current Liabilities0103.0K452.0K378.0K1.0K
Total Liabilities2.3M4.7M3.7M3.0M5.1M
Equity
Total Shareholders Equity-1.4M-2.9M397.0K12.6M25.3M

Balance Sheet Composition

BioSig Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-10.3M-28.7M-27.3M-32.9M-59.1M
Operating Cash Flow-3.2M-20.8M-22.5M-24.2M-29.7M
Investing Activities
Capital Expenditures0-186.0K-168.0K-542.0K-87.0K
Investing Cash Flow0-186.0K-168.0K-542.0K-87.0K
Financing Activities
Dividends Paid-----
Financing Cash Flow4.7M17.3M10.4M10.3M38.0M
Free Cash Flow-4.8M-17.5M-21.9M-26.9M-26.7M

Cash Flow Trend

BioSig Technologies Key Financial Ratios

Valuation Ratios

Forward P/E -9.79
Price to Book 69.53
Price to Sales 39,021.37
PEG Ratio -9.79

Profitability Ratios

Profit Margin 0.00%
Operating Margin -47,726.92%
Return on Equity 739.31%
Return on Assets -258.22%

Financial Health

Current Ratio 2.37
Debt to Equity 2.19
Beta 1.68

Per Share Data

EPS (TTM) -$0.53
Book Value per Share $0.11
Revenue per Share $0.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
bsgm1.0B-69.53739.31%0.00%2.19
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
908 Devices 238.1M-3.121.49-48.15%-27.64%2.36
MaxCyte 230.7M-5.681.16-19.63%-110.92%9.44
Tactile Systems 236.4M15.411.178.12%5.52%21.23

Financial data is updated regularly. All figures are in the company's reporting currency.